Brain Neuromodulation Articles & Analysis: Older
8 news found
The Relivion DP is the first non-invasive, multi-channel brain neuromodulation system for at home treatment of neurological and neuropsychiatric disorders. ...
” Relivion is a non-invasive brain neuromodulation device that is placed around the head and delivers stimulation to the occipital and trigeminal nerves. This creates a cumulative effect by releasing neurotransmitters in the brainstem and modulating brain networks associated with control of pain and mood. The device is designed to be used ...
Teresa Kimberley, PhD, PT, Professor and Director of the Brain Recovery Lab at MGH Institute of Health Professions. The safety of VNS implants has been well established in other clinical areas. ...
Relivion® is the first non-invasive multi-channel brain neuromodulation system for at home treatment of acute migraine, a debilitating neurological disease impacting 39 million people and resulting in 1.2 million emergency department visits annually. ...
Relivion® is a non-invasive brain neuromodulation* device that is placed around the head and delivers unparalleled stimulation to the occipital and trigeminal nerves. ...
Neurolief, a neurotechnology innovator, today announces findings of the RIME US pivotal trial that demonstrate the safety and efficacy of the Relivion®, a novel external brain neuromodulation system for self-administered treatment of migraine. ...
Neurolief, a medical neurotechnology innovator, today announces that the US Food and Drug Administration (FDA) has granted Breakthrough Device designation to the Relivion®DP system, the first non-invasive multi-channel brain neuromodulation technology, for the treatment of major depression. ...
December 19, 2016: In collaboration with researchers at the University of Maryland, WMP presented a poster at the Brain Initiative Investigator Conference in North Bethesda, MD, entitled “Wireless Current Detection Using a Spin-Transfer Nano-Oscillator by Near-Field Induction.” This class of particles shows strong promise as a neuromodulator and ...